Related Experiment Video
Updated: Apr 27, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Assessing additional benefit in noninferiority trials
Meinhard Kieser1, Kathrin Stucke1
1Institute of Medical Biometry and Informatics, University of Heidelberg, Im Neuenheimer Feld 305, D-69120, Heidelberg, Germany.
Abstract:
A method for simultaneously assessing noninferiority with respect to efficacy and superiority with respect to another endpoint in two-arm noninferiority trials is presented. The procedure controls both the average type I error rate for the intersection-union test problem and the frequentist type I error rate for the noninferiority test by α while allowing an increased level for the superiority test. For normally distributed outcomes, two methods are presented to deal with the uncertainty about the correlation between the endpoints which defines the adjusted levels. The operating characteristics of these procedures are investigated. Furthermore, the sample size required when applying the proposed method is compared with that of alternative procedures. Application of the method in the situation of binary endpoints and mixed normal and binary endpoints, respectively, is sketched. An illustrative example is provided demonstrating implementation of the proposed approach in a clinical trial.
More Related Videos
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence studies: Biowaivers
Bioequivalence of Drugs: Drugs with Multiple Indications
Clinical Trials
There are four phases in a clinical trial. A phase one...
Bioequivalence Data: Statistical Interpretation

